Gene · 4241
MELTF: melanotransferrin
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. MELTF: melanotransferrin. Genes, record 4241. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/4241
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P08582 | Melanotransferrin | 738 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents86
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 37629 | P08582 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 3710 | P08582 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 3297 | P08582 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 8536 | P08582 | Espacenet |
| JP 2025532637 A | 2025-10-01 | 108 | P08582 | Espacenet |
| JP 2025532652 A | 2025-10-01 | 108 | P08582 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 7005 | P08582 | Espacenet |
| WO 2025175123 A1 | 2025-08-21 | 108 | P08582 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 7005 | P08582 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 3297 | P08582 | Espacenet |
1 to 10 of 86
See all 86 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants793
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MELTF papers | Newest fiscal year |
|---|---|---|---|
| P30ES006694 | Southwest Environmental Health Sciences Center | 12 | 2025 |
| ZIABC010600 | AAA Proteins, Mechanisms of Their Functions and Related Diseases | 6 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 5 | 2025 |
| ZIADK033008 | Mechanism of protein quality control at the endoplasmic reticulum | 5 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 4 | 2025 |
| T32ES007091 | Training in Environmental Toxicology of Human Disease | 4 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 3 | 2025 |
| P30DK034854 | Integrated Epithelial and Muscosal Biology | 3 | 2025 |
| R01CA163910 | Targeting ER stress response in B-cell chronic lymphocytic leukemia | 3 | 2025 |
| R01GM127557 | Mechanisms regulating ER Proteostasis | 3 | 2025 |
1 to 10 of 793Source NIH's project files
See all 793 nih grantsPapers1,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of melanotransferrin (MFI2) as a membrane target and an MFI2-directed aptamer as a theranostic tool for pancreatic ductal adenocarcinoma. | Talanta | 2027 | 42727242 | PubTator, text mining | PubMed |
| Nucleophagy as an emerging therapeutic vulnerability in cancer. | Autophagy | 2026 | 42495958 | PubTator, text mining | PubMed |
| Preclinical evaluation of 89Zr/177Lu/161Tb-labeled anti-CD228 monoclonal antibody for theranostics in skin cutaneous melanoma. | Eur J Pharm Biopharm | 2026 | 42203156 | PubTator, text mining | PubMed |
| Dual role of the OMM E3 Ub ligase MARCH5 in de novo peroxisome biogenesis and mitochondrial quality control through direct regulation of Pex26. | bioRxiv | 2026 | 42182360 | PubTator, text mining | PubMed |
| A CHK1-mediated phosphorylation switch suppresses human Topoisomerase 1-associated genomic instability. | EMBO J | 2026 | 42129541 | PubTator, text mining | PubMed |
Corrigendum to 'Synthesis and structure-activity relationships of N - (3 - (1H-imidazol-2-yl) phenyl) - 3-phenylpropionamide derivatives as a novel class of covalent inhibitors of p97/VCP ATPase' [ Eur. J. Med. Chem. 248 (2023) 115094]. | Eur J Med Chem | 2026 | 42106196 | PubTator, text mining | PubMed |
| Lipid-anchored melanotransferrin mediates transferrin-independent iron uptake and ferritin storage in mammals. | Cell Death Discov | 2026 | 41997899 | PubTator, text mining | PubMed |
| Programmed cell death: a promising management for Alzheimer's disease. | Apoptosis | 2026 | 41904723 | PubTator, text mining | PubMed |
| Paradoxes in the Ontological Classification of Glia-Evidence for an Important New Class of Brain Cells with Primary Functions in Iron Regulation. | Cells | 2026 | 41892302 | PubTator, text mining | PubMed |
| The role of copper and cuproptosis in digestive system cancers: novel therapeutic strategies and mechanistic insights. | Cancer Biol Ther | 2026 | 41837409 | PubTator, text mining | PubMed |
1 to 10 of 1,420
See all 1,420 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/4241
GET https://conductscience.org/api/genes/v1/4241/patents?page=2